233 related articles for article (PubMed ID: 12383968)
1. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
Pistis M; Ferraro L; Pira L; Flore G; Tanganelli S; Gessa GL; Devoto P
Brain Res; 2002 Sep; 948(1-2):155-8. PubMed ID: 12383968
[TBL] [Abstract][Full Text] [Related]
2. Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors.
Tomasini MC; Ferraro L; Bebe BW; Tanganelli S; Cassano T; Cuomo V; Antonelli T
J Neurosci Res; 2002 May; 68(4):449-53. PubMed ID: 11992471
[TBL] [Abstract][Full Text] [Related]
3. Effects of endogenous glutamate on extracellular concentrations of GABA, dopamine, and dopamine metabolites in the prefrontal cortex of the freely moving rat: involvement of NMDA and AMPA/KA receptors.
Del Arco A; Mora F
Neurochem Res; 1999 Aug; 24(8):1027-35. PubMed ID: 10478942
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
Nava F; Carta G; Colombo G; Gessa GL
Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
[TBL] [Abstract][Full Text] [Related]
5. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration.
Nava F; Carta G; Battasi AM; Gessa GL
Br J Pharmacol; 2000 Jul; 130(6):1201-10. PubMed ID: 10903956
[TBL] [Abstract][Full Text] [Related]
6. The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex.
Welty N; Shoblock JR
Psychopharmacology (Berl); 2009 Dec; 207(3):433-8. PubMed ID: 19795107
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Tanda G; Pontieri FE; Di Chiara G
Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
[TBL] [Abstract][Full Text] [Related]
8. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
Secci ME; Mascia P; Sagheddu C; Beggiato S; Melis M; Borelli AC; Tomasini MC; Panlilio LV; Schindler CW; Tanda G; Ferré S; Bradberry CW; Ferraro L; Pistis M; Goldberg SR; Schwarcz R; Justinova Z
Mol Neurobiol; 2019 May; 56(5):3563-3575. PubMed ID: 30151725
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels.
Ferraro L; Tomasini MC; Cassano T; Bebe BW; Siniscalchi A; O'Connor WT; Magee P; Tanganelli S; Cuomo V; Antonelli T
J Neurosci Res; 2001 Oct; 66(2):298-302. PubMed ID: 11592127
[TBL] [Abstract][Full Text] [Related]
10. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
11. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
Tanda G; Loddo P; Di Chiara G
Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats.
Dazzi L; Talani G; Biggio F; Utzeri C; Lallai V; Licheri V; Lutzu S; Mostallino MC; Secci PP; Biggio G; Sanna E
PLoS One; 2014; 9(3):e92224. PubMed ID: 24632810
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study.
Ferraro L; Tomasini MC; Gessa GL; Bebe BW; Tanganelli S; Antonelli T
Cereb Cortex; 2001 Aug; 11(8):728-33. PubMed ID: 11459762
[TBL] [Abstract][Full Text] [Related]
14. Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat.
Del Arco A; Mora F
Brain Res Bull; 2000 Oct; 53(3):339-45. PubMed ID: 11113590
[TBL] [Abstract][Full Text] [Related]
15. Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
Maneuf YP; Nash JE; Crossman AR; Brotchie JM
Eur J Pharmacol; 1996 Jul; 308(2):161-4. PubMed ID: 8840127
[TBL] [Abstract][Full Text] [Related]
16. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
Kehr J; Yoshitake T; Ichinose F; Yoshitake S; Kiss B; Gyertyán I; Adham N
Psychopharmacology (Berl); 2018 May; 235(5):1593-1607. PubMed ID: 29637288
[TBL] [Abstract][Full Text] [Related]
17. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study.
Bourdelais AJ; Deutch AY
Cereb Cortex; 1994; 4(1):69-77. PubMed ID: 8180492
[TBL] [Abstract][Full Text] [Related]
18. D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex.
Abekawa T; Ohmori T; Ito K; Koyama T
Brain Res; 2000 Jun; 867(1-2):250-4. PubMed ID: 10837822
[TBL] [Abstract][Full Text] [Related]
19. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
[TBL] [Abstract][Full Text] [Related]
20. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
